| [1］ 郭慧敏，赵晋华，宋建华，等.18F-FDG PET-CT在宫颈癌初诊及随访监测中的价值［J］. 肿瘤，2011，31（3）：250-254. [2］ Chou HH,Chang TC,Yen TC. Low value of [18F］-fluoro-2-deoxy-D-glucose positron emission tomography in primary staging of early-stage cervical cancer before radical hysterectomy［J］.J Clin Oncol,2006,24(1):123-128. [3］ Sironi S,Buda A,Picchio M，et al. Lymph node metastasis in patients with clinical early-stage cervical cancer:detection with integrated FDG PET-CT［J］.Radiology,2006,238(1):272. [4］ 郑航，陈锦章，罗荣城，等. 18F-FDG PET-CT显像对宫颈癌诊断及治疗的影响［J］.实用癌症杂志，2009，24（5）：494-497. [5］ Yen TC,See LC,Lai CH，et al. 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression［J］ .J Nucl Med,2004,45(10):22. [6］ Loft A,Berthelsen AK,Roed H. The diagnostic value of PET-CT scanning in patients with cervical cancer:a prospective study［J］.Gynecol Oncol,2007,106(1):29-34. [7］ 卢宝彦，车文颖，姚树展. PET-CT显像在宫颈癌原发灶诊断及盆腔淋巴结分期的价值［J］.医学影像学杂志，2008，18（9）：1052-1054. [8］ Lin WC,Hung YC,Yeh LS. Usefulness of (18) F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings［J］.Gynecol Oncol，2003，89(1)：73-76. [9］ 周文兰，罗湖炳，王全师，等.18F-FDG PET-CT在宫颈癌诊断中的应用［J］.中国核医学杂志，2008,28(3)：178-181. [10］ 陈英汉， 王丹波， 李雅男，等. PET-CT在检测早期子宫颈癌淋巴结转移中的诊断价值［J］.中国医科大学学报，2013,42(4)：351-354. [11］ Amandine P,Caroline BM,Aurore O,et al. Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinoma［J］. Eur J Nucl Med Molec Imaging,2010, 37(7):1270-1278. [12］ Nam HI,Huh SJ,Ju SG,et al.18F-fluorodeoxyglucose positron emisson tomography/computed tomography guided conformal brachytherapy for cervical cancer［J］. Int J Radiat Oncol Biol Phys,2012,84(1):e29-e34. [13］ Chung HH,Kim SK,Kim TH. Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer:from diagnosis to prognosis［J］.Gynecol Oncol,2006,103:165-170. [14］ Sakurai H,Suzuki Y,Nonaka T. FDG-PET in the detection of recurrence of uterine cervical carcinoma following radiation therapy-tumor volume and FDG uptake value［J］. Gynecol Oncol，2006,100:601-607. [15］ Unger JB,Ivy JJ,Connor P.Detection of recurrent cervical cancer by whole-body FDG PET scan in asymptomatic and symptomatic women［J］. Gynecol Oncol，2004,94:212-216. [16］ Chung HH,Nam BH,Kim JW,et al. Preoperative (18F)FDG PET-CT maximum standardized uptake value predicts recurrence of uterine cervical cancer［J］. Eur J Nucl Med and Molec Imaging, 2010, 37(8):1467-1473. [17］ Kidd EA,Siegel BA,Dehdashti P. Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer［J］.Cancer,2010,116(6):1469-1475. [18］ Chang TC,Law KS,Hong JH.Positron emission tomography for unexplained elevation of serum squamous cell carcinoma antigen levels during follow-up for patients with cervical malignancies:a phase II study［J］. Cancer，2004，101：164-171. [19］ Kidd EA,Siegel BA,Dehdashti F,et al. The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival［J］.Cancer,2007,110(8):1738-1744. [20］ Yilmaz M,Adli M,Celen Z,et al. FDG PET-CT in cervical cancer: relationship between primary tumor FDG uptake and metastatic potential［J］. Nucl Med Communications，2010, 31(6)：526-531. [21］ Grigsby PW,Siegel BA,Dehdashti F, et al. Posttherapy [18F］ fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome［J］. J Clin Oncol，2004，22(11)：2167-2171. [22］ Schwarz JK,Siegel BA,Dehdashti F,et al. Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma［J］.JAMA,2007,298(19):2289-2295. |
